Cargando…
Cross-Resistance of Acquired Radioresistant Colorectal Cancer Cell Line to gefitinib and regorafenib
BACKGROUND: Usually, chemoradiotherapy can be used for the treatment of locally advanced colorectal cancer (CRC) before surgery. On the other hand, some studies have shown that fractional radiation of tumor cells leads to chemoresistance. The aim of this study was to evaluate the chemoresistance of...
Autores principales: | Afshar, Saeid, Sedighi Pashaki, Abdolazim, Najafi, Rezvan, Nikzad, Safoora, Amini, Razieh, Shabab, Nooshin, Khiabanchian, Omid, Tanzadehpanah, Hamid, Saidijam, Massoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983275/ https://www.ncbi.nlm.nih.gov/pubmed/32038059 http://dx.doi.org/10.30476/ijms.2019.44972 |
Ejemplares similares
-
DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021) -
The Effect of miR-145-5p, DANCR and NRAS Expression Levels on the Survival Rate of Colorectal Cancer Patients
por: Bahreini, Fatemeh, et al.
Publicado: (2021) -
Hypothyroidism Evaluation after Radiotherapy of Breast and Supraclavicular in Patients with Breast Cancer
por: Karimijavid, Mohammad R., et al.
Publicado: (2023) -
AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017) -
Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer
por: Ganji, Sajjad Mohammad, et al.
Publicado: (2017)